Thursday, April 03, 2014 5:23:52 PM
Voskuhl is brilliant and construction of this trial is solid. Reality is that prior results of 6 study subjects wouldn't even show the possible multiple confounders they will have to crunch out on this study as they're quantifying results. When people who haven't been involved in or studied the clinical trial process want to know whether the results will be good or not - I always make a point to differentiate between an evidence-based response and a personal one. It is important, in my opinion, to structure feedback based on both in order to encourage risk being taken in informed and not emotional way. I hope for and anticipate positive results - but a supporting study of 6 women does not support that hope, nor does it support a negative premise. I'm just a stickler for separating reality-based from emotionally-based response.
Recent TOVX News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 09:23:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 08:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:10:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/16/2026 09:32:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 12:15:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:10:35 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2026 09:35:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:07:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 02:11:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:55:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:54:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:53:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:51:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/06/2026 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 01:00:58 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/23/2025 10:04:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 10:21:47 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/03/2025 09:00:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/03/2025 05:15:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2025 09:11:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:16:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:10:35 PM
